Koers Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Aandelen
688192
CNE1000055W8
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
37,68 CNY | +6,44% | -5,80% | -21,25% |
Omzet 2023 | 91,29 mln. 12,6 mln. 11,83 mln. | Omzet 2024 * | 490 mln. 67,63 mln. 63,51 mln. | Marktkapitalisatie | 15,66 mld. 2,16 mld. 2,03 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 | -1,12 mld. -155 mln. -146 mln. | Nettowinst (verlies) 2024 * | -649 mln. -89,57 mln. -84,12 mln. | EV/omzet 2023 | 214 x |
Nettoliquiditeiten 2023 * | - 0 0 | Nettoliquiditeiten 2024 * | - 0 0 | EV/omzet 2024 * | 32 x |
K/w-verhouding 2023 |
-17,4
x | K/w-verhouding 2024 * |
-24,2
x | Werknemers | 424 |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 18,48% |
1 dag | +6,44% | ||
1 week | -5,80% | ||
Lopende maand | -16,25% | ||
1 maand | -13,22% | ||
3 maanden | -0,45% | ||
6 maanden | +15,65% | ||
Lopend jaar | -21,25% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Xiao Lin Zhang
CEO | Chief Executive Officer | 60 | 27-10-17 |
Wei Wen Dong
CHM | Chairman | 38 | 01-06-18 |
Hong Bin Lu
DFI | Director of Finance/CFO | 46 | 01-07-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Simon Lü
BRD | Director/Board Member | 56 | 01-10-17 |
Xue Gong Wang
BRD | Director/Board Member | 52 | 07-09-20 |
Guan Shan Zhu
BRD | Director/Board Member | 60 | 08-09-20 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
22-04-24 | 37,68 | +6,44% | 2 325 619 |
19-04-24 | 35,4 | -4,71% | 2 408 522 |
18-04-24 | 37,15 | -0,67% | 1 599 289 |
17-04-24 | 37,4 | +0,51% | 1 843 790 |
16-04-24 | 37,21 | -6,97% | 2 385 552 |
slotkoers Shanghai S.E., 22 april 2024
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-21,25% | 2,16 mld. | |
+2,49% | 96,73 mld. | |
-0,06% | 21,31 mld. | |
-16,61% | 21,21 mld. | |
-5,01% | 18,79 mld. | |
-42,14% | 16,37 mld. | |
-27,40% | 13,68 mld. | |
+1,44% | 13,44 mld. | |
+21,29% | 10,98 mld. | |
-21,79% | 8,56 mld. |